Core Insights - OSR Holdings, Inc. has completed a share exchange with Woori IO Co., Ltd., making Woori IO a wholly-owned subsidiary of OSR Holdings' Korean intermediate holding company, OSRK [1][2] - Woori IO is collaborating with Samsung Electronics on a Proof-of-Concept study in South Korea to gain regulatory approval for its noninvasive blood glucose monitoring technology [2][3] - Following the corporate integration, Woori IO plans to initiate U.S. market development activities, including a clinical trial in collaboration with a prestigious California research university [3][4] Company Overview - OSR Holdings, Inc. is a global healthcare holding company focused on biomedical innovation, with interests in immuno-oncology, regenerative biologics, and medical device technologies [5] - Woori IO specializes in noninvasive biosensing technologies for glucose monitoring, utilizing a proprietary NIRS-based system for accurate and pain-free glucose tracking [6]